29/04/2026
We need to talk about s3x and menopause after cancer. Here’s why it matters more than the data usually shows.
A large real-world app-based cohort study (published in Cancers, March 2026) compared menopause-specific health-related quality of life in women with and without a cancer history, using the Cervantes SF-16 scale.
Key finding: global quality-of-life scores were broadly comparable between the groups, but the sexuality domain was significantly worse in women with a cancer history, with the gap largest for non-gynaecological cancers.
Depression was the strongest consistent predictor of poor quality of life across all domains, in both groups.
This is quantitative confirmation of what many MACS women report: the thing that most erodes quality of life is often sexual health and intimacy — and it’s the thing least likely to be raised in a 15-minute oncology follow-up.
The depression finding is also important: it points to the need for integrated mental health support within menopause-after-cancer care, not as an add-on.